Meeder Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-51
| Closed | -$1K | – | 1731 |
|
|
2022
Q3 | $1K | Sell |
51
-86
| -63% | -$1.69K | ﹤0.01% | 2006 |
|
|
2022
Q2 | $3K | Buy |
137
+29
| +27% | +$635 | ﹤0.01% | 1823 |
|
|
2022
Q1 | $4K | Buy |
+108
| New | +$4K | ﹤0.01% | 1875 |
|
|
2021
Q4 | – | Sell |
-1,443
| Closed | -$60K | – | 2080 |
|
|
2021
Q3 | $60K | Buy |
1,443
+1,356
| +1,559% | +$56.4K | ﹤0.01% | 1046 |
|
|
2021
Q2 | $3K | Buy |
87
+66
| +314% | +$2.28K | ﹤0.01% | 2129 |
|
|
2021
Q1 | $1K | Hold |
21
| – | – | ﹤0.01% | 2253 |
|
|
2020
Q4 | $1K | Sell |
21
-8
| -28% | -$381 | ﹤0.01% | 1721 |
|
|
2020
Q3 | $1K | Sell |
29
-64
| -69% | -$2.21K | ﹤0.01% | 2036 |
|
|
2020
Q2 | $3K | Sell |
93
-399
| -81% | -$12.9K | ﹤0.01% | 1688 |
|
|
2020
Q1 | $16K | Buy |
492
+137
| +39% | +$4.46K | ﹤0.01% | 1335 |
|
|
2019
Q4 | $15K | Hold |
355
| – | – | ﹤0.01% | 1440 |
|
|
2019
Q3 | $13K | Buy |
355
+262
| +282% | +$9.59K | ﹤0.01% | 1448 |
|
|
2019
Q2 | $5K | Sell |
93
-2,129
| -96% | -$114K | ﹤0.01% | 1676 |
|
|
2019
Q1 | $128K | Sell |
2,222
-356
| -14% | -$20.5K | 0.01% | 639 |
|
|
2018
Q4 | $109K | Buy |
2,578
+621
| +32% | +$26.3K | 0.01% | 622 |
|
|
2018
Q3 | $148K | Sell |
1,957
-221
| -10% | -$16.7K | 0.01% | 552 |
|
|
2018
Q2 | $156K | Buy |
2,178
+2,012
| +1,212% | +$144K | 0.01% | 542 |
|
|
2018
Q1 | $5K | Sell |
166
-190
| -53% | -$5.72K | ﹤0.01% | 1232 |
|
|
2017
Q4 | $12K | Buy |
356
+331
| +1,324% | +$11.2K | ﹤0.01% | 1079 |
|
|
2017
Q3 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 1560 |
|
|
2017
Q2 | – | Sell |
-93
| Closed | -$2K | – | 1827 |
|
|
2017
Q1 | $2K | Buy |
+93
| New | +$2K | ﹤0.01% | 1395 |
|